The RSI Oscillator for MKGAF moved out of oversold territory on November 22, 2024. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 17 similar instances when the indicator left oversold territory. In of the 17 cases the stock moved higher. This puts the odds of a move higher at .
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Momentum Indicator moved above the 0 level on December 18, 2024. You may want to consider a long position or call options on MKGAF as a result. In of 117 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for MKGAF just turned positive on November 27, 2024. Looking at past instances where MKGAF's MACD turned positive, the stock continued to rise in of 60 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MKGAF advanced for three days, in of 208 cases, the price rose further within the following month. The odds of a continued upward trend are .
MKGAF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The 50-day moving average for MKGAF moved below the 200-day moving average on November 14, 2024. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MKGAF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for MKGAF entered a downward trend on December 02, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.603) is normal, around the industry mean (57.958). P/E Ratio (20.964) is within average values for comparable stocks, (89.727). Projected Growth (PEG Ratio) (3.030) is also within normal values, averaging (2.947). Dividend Yield (0.014) settles around the average of (0.122) among similar stocks. P/S Ratio (3.047) is also within normal values, averaging (19.472).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MKGAF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. MKGAF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
Industry PharmaceuticalsOther
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
JULQ | 25.16 | N/A | N/A |
Innovator Premium Income 40 Bar ETF -Jul | |||
EASG | 29.78 | -0.74 | -2.42% |
Xtrackers MSCI EAFE ESG Leaders Eq ETF | |||
EWS | 21.76 | -0.66 | -2.94% |
iShares MSCI Singapore ETF | |||
FDTX | 35.61 | -1.41 | -3.81% |
Fidelity Disruptive Technology ETF | |||
QTEC | 191.38 | -8.56 | -4.28% |
First Trust NASDAQ-100-Tech Sector ETF |
A.I.dvisor indicates that over the last year, MKGAF has been loosely correlated with MKKGY. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if MKGAF jumps, then MKKGY could also see price increases.
Ticker / NAME | Correlation To MKGAF | 1D Price Change % | ||
---|---|---|---|---|
MKGAF | 100% | +0.95% | ||
MKKGY - MKGAF | 49% Loosely correlated | -1.16% | ||
AQST - MKGAF | 19% Poorly correlated | -10.13% | ||
INDV - MKGAF | 17% Poorly correlated | -2.87% | ||
EVO - MKGAF | 17% Poorly correlated | -9.41% | ||
EBS - MKGAF | 16% Poorly correlated | -7.17% | ||
More |